Login / Signup

Safety and efficacy of orally administered telmisartan for the treatment of systemic hypertension in cats: Results of a double-blind, placebo-controlled, randomized clinical trial.

Amanda E ColemanScott A BrownAnne M TraasLawrence BrysonTanja ZimmeringAlicia Zimmerman
Published in: Journal of veterinary internal medicine (2019)
Telmisartan significantly decreased SBP to a clinically relevant extent and was well tolerated in hypertensive cats.
Keyphrases
  • blood pressure
  • double blind
  • placebo controlled
  • study protocol
  • clinical trial
  • randomized controlled trial
  • squamous cell carcinoma
  • phase iii
  • smoking cessation
  • replacement therapy
  • rectal cancer